Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

170 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study.
Grunfeld C, Kotler DP, Dobs A, Glesby M, Bhasin S. Grunfeld C, et al. Among authors: glesby m. J Acquir Immune Defic Syndr. 2006 Mar;41(3):304-14. doi: 10.1097/01.qai.0000197546.56131.40. J Acquir Immune Defic Syndr. 2006. PMID: 16540931 Clinical Trial.
Two hundred sixty-two HIV-infected men with documented 10% to 20% weight loss or body mass index < or =20 kg/m were randomized to placebo or to 20, 40, or 80 mg of oxandrolone daily. ...

Two hundred sixty-two HIV-infected men with documented 10% to 20% weight loss or body mass index < or =20 kg/m were randomized to

Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV-infected women.
Cocohoba J, Wang QJ, Cox C, Gange SJ, Cohen M, Glesby M, DeHovitz JA, Greenblatt RM. Cocohoba J, et al. Among authors: glesby m. J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):377-83. doi: 10.1097/QAI.0b013e318160d552. J Acquir Immune Defic Syndr. 2008. PMID: 18176324
The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women.
Maurer T, Rodrigues LK, Ameli N, Phanuphak N, Gange SJ, DeHovitz J, French AL, Glesby M, Jordan C, Khalsa A, Hessol NA. Maurer T, et al. Among authors: glesby m. Clin Infect Dis. 2004 Feb 15;38(4):579-84. doi: 10.1086/381264. Epub 2004 Jan 30. Clin Infect Dis. 2004. PMID: 14765353
Abdominal Fat Depots and Subclinical Carotid Artery Atherosclerosis in Women With and Without HIV Infection.
Glesby MJ, Hanna DB, Hoover DR, Shi Q, Yin MT, Kaplan R, Tien PC, Cohen M, Anastos K, Sharma A. Glesby MJ, et al. J Acquir Immune Defic Syndr. 2018 Mar 1;77(3):308-316. doi: 10.1097/QAI.0000000000001606. J Acquir Immune Defic Syndr. 2018. PMID: 29210836 Free PMC article.
Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy.
Marks KM, Clarke RM, Bussel JB, Talal AH, Glesby MJ. Marks KM, et al. Among authors: glesby mj. J Acquir Immune Defic Syndr. 2009 Dec;52(5):595-9. doi: 10.1097/QAI.0b013e3181b79aff. J Acquir Immune Defic Syndr. 2009. PMID: 19734800 Free PMC article.
Changes in metabolic syndrome status after initiation of antiretroviral therapy.
Krishnan S, Schouten JT, Atkinson B, Brown TT, Wohl DA, McComsey GA, Glesby MJ, Shikuma C, Haubrich R, Jacobson DL. Krishnan S, et al. Among authors: glesby mj. J Acquir Immune Defic Syndr. 2015 Jan 1;68(1):73-80. doi: 10.1097/QAI.0000000000000397. J Acquir Immune Defic Syndr. 2015. PMID: 25321179 Free PMC article.
Pilot study of pioglitazone before HCV retreatment in HIV/HCV genotype 1-infected subjects with insulin resistance and previous nonresponse to peginterferon and ribavirin therapy: A5239.
Marks KM, Kitch D, Chung RT, Hadigan C, Andersen J, Tien P, Luetkemeyer A, Alston-Smith B, Glesby MJ; A5239 Team. Marks KM, et al. Among authors: glesby mj. J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):345-9. doi: 10.1097/QAI.0000000000000073. J Acquir Immune Defic Syndr. 2014. PMID: 24525470 Free PMC article. Clinical Trial.
Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals.
Krishnan S, Schouten JT, Atkinson B, Brown T, Wohl D, McComsey GA, Glesby MJ, Shikuma C, Haubrich R, Tebas P, Campbell TB, Jacobson DL. Krishnan S, et al. Among authors: glesby mj. J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):381-9. doi: 10.1097/QAI.0b013e3182690e3c. J Acquir Immune Defic Syndr. 2012. PMID: 22828718 Free PMC article. Clinical Trial.
Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin.
Talal AH, Liu RC, Zeremski M, Dimova R, Dove L, Pearce D, Hassanein T, Doonquah L, Aboulafia D, Rodriguez J, Bonilla H, Galpin J, Aberg JA, Johnston B, Glesby MJ, Jacobson IM. Talal AH, et al. Among authors: glesby mj. J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):261-8. doi: 10.1097/QAI.0b013e3182324af9. J Acquir Immune Defic Syndr. 2011. PMID: 21876446 Free PMC article. Clinical Trial.
Case-control study of diabetes mellitus in HIV-infected patients.
Yoon C, Gulick RM, Hoover DR, Vaamonde CM, Glesby MJ. Yoon C, et al. Among authors: glesby mj. J Acquir Immune Defic Syndr. 2004 Dec 1;37(4):1464-9. doi: 10.1097/01.qai.0000137373.26438.18. J Acquir Immune Defic Syndr. 2004. PMID: 15602124

RESULTS: Compared with matched controls, case patients had higher mean body mass index (BMI; 30.0 vs. 25.3 kg/m, matched odds ratio [OR] = 1.20; P < 0.001), higher alanine aminotransferase (ALT; 66 vs. 44 U/L, OR = 1.12 per 10 U/L; P = 0.013), and stronger family histor

RESULTS: Compared with matched controls, case patients had higher mean body mass index (BMI; 30.0 vs. 25.3 kg/m, matched odds ratio [ …
170 results
Jump to page
Feedback